Litigation Details for ASTRAZENECA AB v. APOTEX CORP. (D.N.J. 2015)
✉ Email this page to a colleague
ASTRAZENECA AB v. APOTEX CORP. (D.N.J. 2015)
Docket | ⤷ Sign Up | Date Filed | 2015-05-15 |
Court | District Court, D. New Jersey | Date Terminated | 2017-06-05 |
Cause | 35:271 Patent Infringement | Assigned To | Freda L. Wolfson |
Jury Demand | None | Referred To | Douglas Arpert |
Parties | ASTRAZENECA PHARMACEUTICALS LP | ||
Patents | 8,536,206; 8,604,064; 8,618,142 | ||
Attorneys | JOHN EDMUND FLAHERTY | ||
Link to Docket | External link to docket |
Small Molecule Drugs cited in ASTRAZENECA AB v. APOTEX CORP.
Details for ASTRAZENECA AB v. APOTEX CORP. (D.N.J. 2015)
Date Filed | Document No. | Description | Snippet | Link To Document |
---|---|---|---|---|
2015-05-15 | 1 | expiration of U.S. Patent Nos. 8,536,206 (the “’206 patent”); 8,604,064 (the “’064 patent”); and 8,618,142…. This is an action for patent infringement arising under the patent laws of the United States, …8,618,142 (the “’142 patent”) (collectively, the “patents-in-suit”). … PATENTS-IN-SUIT 17. On September 17, 2013, the U.S. Patent and Trademark …copy of the ’206 patent is attached hereto as Exhibit A. The claims of the ’206 patent are valid and | External link to document | |
>Date Filed | >Document No. | >Description | >Snippet | >Link To Document |